Singer M, Deutschman CS, Seymour CW, et al.The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810. doi: 10.1001/jama.2016.0287.
Qiu Y, Bi H, Xie W, et al.The immunometabolic axis of sepsis-related myocardial injury: macrophage reprogramming as a central mechanism and therapeutic target. Front Immunol. 2026;17:1779575. doi: 10.3389/fimmu.2026.1779575.
Iqbal MS, Khan MF, Farooqui S, et al.Exploring the mechanisms and management of sepsis-related cardiac dysfunction. Acta Cardiol. 2026:1–17. doi: 10.1080/00015385.2026.2664100.
Huespe I, Sosa FA, Jena A, et al.Long-term outcomes of abnormal global longitudinal left ventricular strain during sepsis: a retrospective cohort study. J Crit Care. 2026;93:155442. doi: 10.1016/j.jcrc.2026.155442.
Gu J, Lin D, Yu H., Effect of the cardiac troponin-T trajectory on the mortality and new-onset atrial fibrillation in patients with sepsis: a retrospective cohort study from the MIMIC IV database. Heart Lung. 2026;78:102746. doi: 10.1016/j.hrtlng.2026.102746.
Orso D, Copetti R., Adrenergic overstimulation: a neglected mechanism of sepsis-related cardiomyopathy. Chest. 2019;155(3):647. doi: 10.1016/j.chest.2018.09.032.
Sinha P, Kerchberger VE, Willmore A, et al.Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials. Lancet Respir Med. 2023;11(11):965–974. doi: 10.1016/S2213-2600(23)00237-0.